Zelira Therapeutics Limited (ASX:ZLD)
Australia · Delayed Price · Currency is AUD 0.4100
0.00 (0.00%)
Aug 8, 2025, 3:42 PM AEST
Altus Power Market Cap
Zelira Therapeutics has a market cap or net worth of 4.88 million as of August 8, 2025. Its market cap has decreased by -43.06% in one year.
Market Cap
4.88M
Enterprise Value
11.57M
Revenue
40.88K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.41
Market Cap Chart
Since November 22, 2016, Zelira Therapeutics's market cap has decreased from 15.39M to 4.88M, a decrease of -68.31%. That is a compound annual growth rate of -12.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 8, 2025 | 4.88M | -30.67% |
| Dec 31, 2024 | 7.04M | -31.11% |
| Dec 29, 2023 | 10.21M | 6.63% |
| Dec 30, 2022 | 9.58M | -77.35% |
| Dec 31, 2021 | 42.28M | -61.23% |
| Dec 31, 2020 | 109.05M | 161.28% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Nov 22, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 128.57B |
| Pro Medicus | 33.41B |
| Cochlear | 20.53B |
| Sonic Healthcare | 13.76B |
| Ramsay Health Care | 8.71B |
| Telix Pharmaceuticals | 6.16B |
| Ansell | 4.50B |
| Mesoblast | 3.02B |